Wound Management News

BMG Pharma announced it has launched its proprietary Ialuxid gel in the People’s Republic of China for the treatment of post-surgical wounds.

Patients treated with carbon dioxide laser evaporation for hidradenitis suppurativa reported satisfaction with the procedure despite a more than 29% recurrence rate of lesions, according to study results.

Recent FDA developments related to dermatology included the agency granting priority review to cobimetinib combined with Zelboraf for advanced melanoma.

While it is certain that health care-associated methicillin-resistant Staphylococcus aureus infections lead to increased mortality, length of hospital stay and costs, the evidence is mixed regarding standard procedures to prevent and control MRSA infections that occur in the health care setting.   

Actavis announced that the FDA has accepted a supplemental new drug application for the label expansion of Teflaro for the treatment of concurrent bacteremia in patients with acute bacterial skin and skin structure infections caused by susceptible isolates of Staphyloccus aureus.

Based on the results of a chart review, researchers determined mild perioperative hypothermia appeared to be unrelated to wound complications.

Researchers found wound eversion was not significantly associated with overall scar improvement in a randomized, split-scar intervention involving cutaneous surgery patients.

Controlling procedural pain in the debridement of scleroderma-associated digital ulcers led to better outcomes and treatment adherence among patients, according to new research.

Postarticular skin was an effective donor site for small- to moderate-sized split-thickness skin grafts for patients after Mohs micrographic surgery, according to study results.

Integra LifeSciences Holdings has introduced the Integra Meshed Dermal Regeneration Template, which received pre-market approval from the U.S. Food and Drug Administration for third-degree burns and scar contracture procedures, according to a press release.